Epoxyeicosatrienoic Acids Contribute With Altered Nitric Oxide and Endothelin-1 Pathways to Conduit Artery Endothelial Dysfunction in Essential Hypertension | Zendy

Jérémy Bellien | Zendy; Michèle Iacob | Zendy; Isabelle RémyJouet | Zendy; Danièle Lucas | Zendy; Christelle Monteil | Zendy; Laurence Gutierrez | Zendy; Cathy Vendeville | Zendy; Yvonne Dréano | Zendy; Alain Mercier | Zendy; Christian Thuillez | Zendy; Robinson Joannidès | Zendy

Open Access

Epoxyeicosatrienoic Acids Contribute With Altered Nitric Oxide and Endothelin-1 Pathways to Conduit Artery Endothelial Dysfunction in Essential Hypertension

Author(s) -

Jérémy Bellien,

Michèle Iacob,

Isabelle RémyJouet,

Danièle Lucas,

Christelle Monteil,

Laurence Gutierrez,

Cathy Vendeville,

Yvonne Dréano,

Alain Mercier,

Christian Thuillez,

Robinson Joannidès

Publication year - 2012

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.070680

Subject(s) - medicine , fluconazole , nitric oxide , endothelial dysfunction , essential hypertension , endothelin 1 , reactive hyperemia , reactive oxygen species , vasodilation , endothelium , brachial artery , endocrinology , omega n methylarginine , endothelin receptor , cardiology , pharmacology , nitric oxide synthase , blood pressure , biochemistry , chemistry , antifungal , receptor , dermatology

We sought to clarify, using functional and biological approaches, the role of epoxyeicosatrienoic acids, nitric oxide (NO)/reactive oxygen species balance, and endothelin-1 in conduit artery endothelial dysfunction during essential hypertension.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research